TDS and Array to release third quarter operating results and host conference call November 6, 2026

News provided by

Telephone and Data Systems, Inc. and Array Digital Infrastructure, Inc.

Oct 30, 2026, 07:30 ET

CHICAGO, Oct. 30, 2026 /PRNewswire/ -- Telephone and Data Systems, Inc. (NYSE: TDS) and Array Digital Infrastructure, Inc. (NYSE: AD) will webcast their third quarter operating results conference call on November 6, 2026, at 9:00 a.m. Central Time.

The companies will release their financial results on November 6, 2026.

To listen to the webcast, please visit the events & presentations pages of investors.tdsinc.com or investors.arrayinc.com. The presentations will be webcast both live and on demand. It is recommended that you register at least 15 minutes before the beginning of the presentation to register, download, and install any necessary multimedia streaming software.

About TDS 

Founded in 1969, Telephone and Data Systems provides broadband services and wireless infrastructure through its businesses, TDS Telecom and Array Digital Infrastructure, Inc.

For more information about TDS and its subsidiaries, visit: 

TDS®: tdsinc.com 

ArraySM: arrayinc.com

TDS Telecom: tdstelecom.com

SOURCE Telephone and Data Systems, Inc. and Array Digital Infrastructure, Inc.

Share this article

Hit Fortune Marks Two-Year Anniversary as Daily Active Users Surpass 100,000

Social gaming platform enters its third year with a growing player community and an expanding selection of entertainment-focused games

MIAMI, Oct. 30, 2026 /PRNewswire/ -- Hit Fortune, a free-to-play social gaming platform, announced that it surpassed 100,000 daily active users as it marked its two-year anniversary on Sept. 26. The milestone comes as Hit Fortune has expanded its game portfolio to more than 1,000 slot-style titles and fostered continuous growth within its social gaming community.

Over the past two years, Hit Fortune has focused on developing a mobile gaming experience designed to be accessible, easy to navigate, and tailored to diverse player preferences. The platform combines a broad selection of slot-style games with features designed to help players discover and return to content they enjoy.

Expanding a Diverse Game Library

A key part of Hit Fortune's growth has been the expansion of its game portfolio. The platform now offers more than 1,000 slot-style titles, spanning a range of themes, visual styles, and gameplay experiences, with new titles added on a weekly basis. The portfolio includes both third-party titles and games developed in-house by Game Wonder, the studio behind Hit Fortune.

To help players navigate the growing selection, Hit Fortune's game lobby includes search functionality, developer-based browsing, and a favorites system, enabling users to easily locate and revisit their preferred titles.

A Focus on Accessible Mobile Entertainment

Hit Fortune is designed with a straightforward user experience, including simplified onboarding and in-app guidance to help new users get started seamlessly.

The platform also offers guest-mode access, allowing users to explore the platform before registering. Search and navigation tools within the game lobby further simplify the process of finding and playing games.

Continuing to Build for Its Growing Community

The 100,000 daily active user milestone comes as Hit Fortune enters its third year, with the platform continuing to invest in content expansion, product improvements, and player experience.

"Reaching our two-year anniversary and surpassing 100,000 daily active users represents an important milestone for Hit Fortune and the entire Game Wonder team," said Max, CEO of Game Wonder. "As we enter our third year, we will continue to expand our game portfolio by introducing more popular and engaging titles, further enriching our gaming platform and providing players with a broader range of entertainment options."

About Hit Fortune

Hit Fortune is a free-to-play social gaming platform offering slot-style mobile entertainment experiences for adult players across North America. With more than 1,000 slot-style titles and player-focused discovery features, Hit Fortune provides a diverse selection of mobile entertainment experiences that are both easily accessible and highly engaging.

Website: https://hitfortune.com/

SOURCE Game Wonder Limited

Share this article

SÃO JOSÃ DOS CAMPOS, Brazil, Oct. 30, 2026 /PRNewswire/ -- Embraer (NYSE: EMBJ; B3: EMBJ3) announced today that it will conduct a forward split of its American Depositary Shares (ADS) and change the ratio of its ADSs to common shares change from the current ratio of one (1) ADS representing four (4) common shares to a new ratio of one (1) ADS representing one (1) common share. The ratio change will be effected through an amendment to the Embraer's Third Amended and Restated Deposit Agreement.

Each holder of record of ADSs as of the close of trading on November 9, 2026 (the record date) will receive, after the close of trading on November 13, 2026, three additional ADSs for every ADS held on the record date. Trading is expected to begin on a split-adjusted basis under the new ratio at market open on November 16, 2026.

The ratio change will not affect Embraer's underlying common shares, and no new common shares will be issued in connection with the ratio change. Similarly, there will be no change in the economic value of the ADS holders' ownership interests.

Embraer's ADSs will continue to trade on the New York Stock Exchange under the ticker symbol "EMBJ". JPMorgan Chase Bank, N.A., as depositary for Embraer's ADS program, will implement the ratio change.

About Embraer

A global aerospace company headquartered in Brazil, Embraer operates in the Commercial Aviation, Executive Aviation, Defense & Security and Agricultural Aviation segments. The Company designs, develops, manufactures and markets aircraft and systems, and provides after-sales Services & Support to customers.

Since its foundation in 1969, Embraer has delivered more than 9,000 aircraft. On average, every 10 seconds, an aircraft manufactured by Embraer takes off from somewhere in the world, transporting more than 150 million passengers annually.

Embraer is a leading manufacturer of commercial jets up to 150 seats and the a major global player in executive aviation and defense & security. The company maintains industrial units, offices, service centers and parts distribution, among other activities, in the Americas, Africa, Asia and Europe.

SOURCE Embraer S.A.

Share this article

Featuring one-second coil saturation, a 10 mL refillable pod and Tri-Core Mesh Technology, VAST delivers a faster, more versatile and longer-lasting experience

SHENZHEN, China, Oct. 30, 2026 /PRNewswire/ -- VAPORESSO, a global vaping technology brand, today introduced VAST, a refillable pod system designed to deliver greater convenience, versatility and lasting performance. Built around the concept of "VAST, FAST, LAST," the device features no-wait priming, Tri-Core Mesh Technology and a high-capacity design in one streamlined platform for adult users.

According to VAPORESSO, VAST is the industry's first open-system device that requires no priming wait. Its innovative wicking structure enables the coil to become fully saturated in just one second after filling, allowing users to begin almost immediately. This eliminates the several-minute wait commonly associated with refillable devices while helping reduce dry hits caused by insufficient priming.

With a total e-liquid capacity of 10 mL, VAST allows users to go longer between refills, minimizing interruptions and providing greater convenience for everyday use and travel. Its streamlined design combines a 2 mL pod with an 8 mL refill container and was developed with applicable TPD capacity requirements in mind.

VAPORESSO also unveils the new Tri-Core Mesh Technology, which integrates three resistance levelsâ0.8Ω, 0.6Ω and 0.4Ωâinto a single pod. Users can switch between ECO, NOR and PWR modes with one click, without replacing the pod or coil. ECO Mode supports smoother, longer-lasting use; NOR Mode balances flavor and vapor for everyday use; and PWR Mode delivers more intensive flavor and vapor production.

For longer-lasting and cleaner performance, VAST incorporates CORE GUARD Technology, featuring a nano-scale coating that helps protect the heating wire against e-liquid corrosion. Under VAPORESSO's testing conditions, each pod supports up to six refills while maintaining stable performance. Upgraded SSS 3.0 Leak-Resistant Technology further helps manage e-liquid and condensation, reducing leakage during daily use and travel.

By combining industry-first no-wait priming, three experiences in one pod and a compliance-conscious high-capacity structure, VAPORESSO VAST offers adult users more choice, less waiting and fewer interruptions.

About VAPORESSO

VAPORESSO develops vaping products and technologies with a focus on quality, user-centered design and technological innovation. Through continued advances in heating systems, leak resistance and product engineering, the brand aims to provide reliable and intuitive experiences for adult users worldwide.

Share this article

Maryland court rules that landmark 1998 tobacco settlement does not bar Baltimore's environmental claims, rejects companies' bid to offset potential damages against state settlement payments, and allows design-defect claims to proceed

NEW YORK, Oct. 30, 2026 /PRNewswire/ -- Milberg PLLC secured a significant legal victory on behalf of the City of Baltimore in its lawsuit against tobacco manufacturers Philip Morris USA Inc., R.J. Reynolds Tobacco Company, and Liggett Group LLC, as well as distributor The George J. Falter Company, seeking to hold them accountable for the environmental damage and cleanup costs caused by discarded plastic cigarette filters. Milberg PLLC represents the City alongside co-counsel Napoli Shkolnik PLLC and Kanner & Whiteley, LLC.

In an extraordinary affirmative win for a plaintiff, the Circuit Court for Baltimore City granted the City's cross-motion for summary judgment on the Master Settlement Agreement (MSA) issues, determining that Baltimore was not a "Releasing Party" under the agreement because Maryland's Attorney General lacked the authority to release claims on behalf of political subdivisions when the MSA was executed in 1998.

In a Memorandum Opinion and Order, Judge Audrey J.S. Carrión further held that the City's claims were not "Released Claims" because "the MSA is fundamentally health-related in both its character and purpose, addressing youth smoking and the effect of smoking on public health," whereas "harm to the environment...provides the basis of the City's claims." On that same basis, the Court rejected the tobacco companies' bid to offset any judgment against their annual MSA payments to Maryland, ruling that the agreement's offset provision applies only to Released Claims. The Court separately denied the tobacco companies' own motion for summary judgment and denied in part their renewed motion to dismiss for failure to state a claim.

The Court also determined that the City's claims for design defect remained viable, rejecting the companies' arguments for dismissal based on the absence of allegations establishing harm to cigarette consumers and that the companies had sufficient control over the product.

"This ruling confirms what we have argued from the outset: the 1998 Master Settlement Agreement was never intended to shield tobacco companies from accountability for the environmental consequences of their products," said Zachary Howerton, Partner at Milberg. "Baltimore never surrendered its right to pursue these claims, and the Court has now affirmed that the City can proceed with its design-defect claims against the manufacturers. For decades, tobacco companies have profited from selling cigarettes containing non-biodegradable plastic filters, while municipalities and their taxpayers have been left to bear the enormous costs of cleaning up the resulting environmental contamination. This decision represents a significant step toward shifting that burden from the taxpayers of Baltimore to the companies responsible for producing these products."

According to the World Health Organization, cigarette butts are "the most littered item on the planet," with an estimated 4.5 trillion littered worldwide every year. Tobacco product litter makes up an estimated 25 to 40 percent of all litter collected globally. Cigarette filters are made of cellulose acetate, a non-biodegradable plastic, and as they break down, they leach nicotine, heavy metals, and other absorbed chemicals into soil and waterways.

Each year, Baltimore City collects more than 2,600 tons of litter at a cost to taxpayers of more than $32 million, with cigarette filters making up a significant portion of that waste. Between 2014 and 2022, the City's "Mr. Trash Wheel" alone collected over 12.4 million cigarette filters from the Inner Harbor. The lawsuit seeks to recover the portion of those cleanup costs attributable to cigarette filters and to compel changes to the design of filtered cigarettes that will lessen their environmental impact.

"What Baltimore has pulled out of its own harbor is just one city's share of a global problem," said Marc Grossman, Senior Partner at Milberg. "This result is also a credit to Sara Gross and the City's Law Department; their partnership and persistence on this case from the outset helped get us here, and we look forward to continuing to work alongside the City to see it through."

Milberg's Howerton and Napoli Shkolnik's Coral M. Odiot Rivera serve as co-chairs, alongside Verónica N. Vázquez-Santiago, also of Napoli Shkolnik, of the American Association for Justice's (AAJ) Microplastics Litigation Group, formed earlier this year to coordinate strategy among plaintiffs' attorneys pursuing microplastics claims nationally. Milberg currently represents the City of Baltimore in two separate microplastics-related suits: this cigarette filter case against tobacco manufacturers, filed in 2022, and a 2024 case against plastics companies.

About Milberg's Environmental Litigation Practice

Milberg's environmental litigation team has spent more than fifty years representing municipalities, water utilities, and public agencies in complex contamination and mass tort cases, including the Camp Lejeune water litigation, the Norfolk Southern derailment spill, AFFF/PFAS claims nationwide, and claims brought by Brazilian municipalities following the 2015 Fundão dam collapse. The firm has recovered more than $50 billion for its clients over its history.

SOURCE Milberg

Share this article

Exclusive licensing agreement with Elegen and acquisition of SynPlexity strengthen gene synthesis capabilities, expand high-throughput discovery workflows, and position GENEWIZ for long-term growth

BURLINGTON, Mass., Oct. 30, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced strategic investments to advance the next phase of growth for its GENEWIZ business. Building on its trusted brand, scientific expertise, global commercial engine, and operational infrastructure, Azenta is expanding its capabilities through an exclusive licensing agreement with Elegen Corp., a developer of advanced cell-free DNA manufacturing technology, and the acquisition of SynPlexity Inc., a synthetic biology company providing high-throughput gene libraries for biological discovery.

The license agreement with Elegen brings into the GENEWIZ portfolio an innovative cell-free DNA synthesis platform designed to improve DNA quality, delivery speed, and manufacturing scalability. Its capabilities include sequence-verified DNA constructs and templates to simplify preparation for downstream experiments, including antibody discovery. The compact production workflows also enable regional capacity to be added close to customers to respond to demand as needed.

Azenta has also acquired SynPlexity, adding pooled gene assembly technology that provides thousands of full-length gene variants in a single library. These capabilities address the increasing scale of biological design by enabling researchers to efficiently build and test large numbers of candidates, including AI-generated designs.

"These strategic investments strengthen the competitive position of GENEWIZ by expanding the products and capabilities we can bring to customers and are key to accelerating our growth," said Trey Martin, President, Multiomics at Azenta. "By combining these advanced technologies with our global infrastructure and existing gene-to-antibody portfolio, we are building a differentiated platform poised to accelerate the next era of biologics discovery and development."

Since its founding in New Jersey in 1999, GENEWIZ has built a global sequencing and gene synthesis business grounded in scientific expertise, customer focus, and operational excellence. These investments complement and extend that foundation into higher-growth applications across synthetic biology, protein engineering, and AI-enabled drug discovery.

Additional details will be provided during Azenta's fourth quarter fiscal 2026 earnings call.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.

Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com

About Elegen 

Elegen uses proprietary cell-free technologies to build longer, higher-quality DNA on a faster timeline for agricultural, chemical, healthcare, and pharma industries.

About SynPlexity 

SynPlexity is a DNA assembly technology company providing products and services centered on large, multiplexed libraries for functional screening, drug discovery, therapeutics, and other applications.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Azenta's plans to develop, integrate, manufacture and commercialize products using the licensed and acquired technologies and the anticipated benefits of the transactions, including expected improvements in gene synthesis capabilities, expansion of the GENEWIZ offerings and markets, customer adoption and demand, and financial, operational and strategic benefits. Actual results could differ materially from those expressed or implied due to risks and uncertainties, including Azenta's ability to transfer, validate, integrate and scale the technologies, achieve expected technical and commercial performance, protect relevant intellectual property and realize the anticipated benefits, as well as the risks described under "Risk Factors" in Azenta's Annual Report on Form 10-K for the fiscal year ended September 30, 2025, as updated or supplemented by subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and Azenta undertakes no obligation to update them except as required by law.

INVESTOR CONTACT for Azenta Life Sciences:

Yvonne Perron

Vice President, Financial Planning & Analysis, and Investor Relations

[email protected]

Maria Isabel Cuartas

Manager, Investor Relations

[email protected]

SOURCE Azenta

Share this article

Company to hold a conference call at 8AM ET on November 5, 2026 to review results and provide a corporate update

SHELTON, Conn., Oct. 30, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to kill tumors and increase immune system recognition of cancers using its proprietary non-covalent conjugation technology, today announced that it will report financial results for the third quarter ended September 30, 2026, before the market opens on November 5, 2026.

Management will host a conference call and live webcast at 8:00 a.m. Eastern time that day to review financial results and provide an update. The archived webcast will be available for replay shortly after the close of the call.

Conference Call Details

Date: November 5, 2026

Time: 8:00 a.m. Eastern Time

Domestic Dial-In: (866) 652-5200

International Dial-In: (412) 317-6060

Webcast URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=b5XzhWmO

About INT230-6

INT230-6, Intensity's lead proprietary investigational product candidate, is designed for direct intratumoral injection. INT230-6 was discovered using Intensity's proprietary DfuseRxâ technology platform. The drug consists of two proven, potent anti-cancer agents, cisplatin and vinblastine sulfate, and a diffusion and cell penetration enhancer molecule ("SHAO") that non-covalently conjugates to the two payload drugs, facilitating the dispersion of potent cytotoxic drugs throughout tumors and allowing the active agents to diffuse into cancer cells. These agents remain in the tumor, resulting in a favorable safety profile. In addition to local disease control and direct tumor killing, INT230-6 causes a release of a bolus of neoantigens specific to the malignancy, leading to immune system engagement and systemic anti-tumor effects. Importantly, these effects are mediated without immunosuppression, which often occurs with systemic chemotherapy.

About Intensity Therapeutics

Intensity is a late-stage clinical biotechnology company whose novel engineered chemistry enables aqueous cytotoxic-containing drug formulations to mix and saturate a tumor's dense, high-fat, pressurized environment following direct intratumoral injection. As a result of the saturation, Intensity's clinical trials have demonstrated the ability of INT230-6 to kill tumors and elicit an adaptive immune response within days of injection, representing a new approach to cancer cell death that holds the potential to shift the treatment paradigm and turn many deadly cancers into chronic diseases even for malignancies that do not respond to conventional immunotherapy. Intensity has completed two clinical studies that enrolled over 200 patients using INT230-6: a Phase 1/2 dose escalation study in metastatic cancers including sarcomas (NCT03058289), and a Phase 2 randomized control clinical trial in locally advanced breast cancer (the "INVINCIBLE-2 Study") (NCT04781725) in women without undergoing chemotherapy prior to their surgery. The Company initiated a Phase 3 trial in soft tissue sarcoma (the "INVINCIBLE-3 Study") (NCT06263231), testing INT230-6 as second or third-line monotherapy compared to the SOC with overall survival as an endpoint. Intensity also initiated a Phase 2 study in collaboration with the Swiss Cancer Institute (the "INVINCIBLE-4 Study") (NCT06358573) as part of a Phase 2/3 program evaluating INT230-6 followed by the SOC immunochemotherapy and the SOC alone for patients with presurgical triple-negative breast cancer. pCR is the endpoint. For more information about Intensity, including publications, papers, and posters about its novel approach to cancer therapeutics, visit www.intensitytherapeutics.com or review our SEC filings.

Forward-Looking Statements

Certain statements in this press release may constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995, as amended to date. These statements include, but are not limited to, statements relating to the Company's expected future plans, cash runway, development activities, projected milestones, business activities or results. When or if used in this communication, the words "may," "could," "should," "anticipate," "believe," "estimate," "expect," "intend," "plan," "predict" and similar expressions and their variants, as they relate to the Company or its management, may identify forward-looking statements. The forward-looking statements contained in this press release are based on management's current expectations and projections about future events. Nevertheless, actual results or events could differ materially from the plans, intentions, and expectations disclosed in, or implied by, the forward-looking statements. These risks and uncertainties, many of which are beyond our control, include: the initiation, timing, progress and results of future preclinical studies and clinical trials and research and development programs; the need to raise additional funding before the Company can expect to generate any revenues from product sales; plans to develop and commercialize product candidates; the timing or likelihood of regulatory filings and approvals; the ability of the Company's research to generate and advance additional product candidates; the risk that product candidates that appear promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical trials; the implementation of the Company's business model, strategic plans for the Company's business, product candidates and technology; commercialization, marketing and manufacturing capabilities and strategy; the rate and degree of market acceptance and clinical utility of the Company's system; the Company's competitive position; the Company's intellectual property position; developments and projections relating to the Company's competitors and its industry; the Company's ability to maintain and establish collaborations or obtain additional funding; expectations related to the use of cash and cash equivalents and investments; our potential inability to satisfy the Nasdaq Capital Market's requirements for continued listing and be subject to delisting; estimates regarding expenses, future revenue, capital requirements and needs for additional financing; and other risks described in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and in the Company's subsequent SEC ï¬lings, which can be obtained on the SEC website at www.sec.gov. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management's current estimates, projections, expectations and beliefs. The Company does not plan to update any such forward-looking statements and expressly disclaims any duty to update the information contained in this press release except as required by law.

Investor Relations Contact:

Justin Kulik

CORE IR

[email protected]

(516) 222-2560

Media Contact:

Matt Cossel

CORE IR

[email protected] 

SOURCE Intensity Therapeutics Inc.

Share this article

The new card offers more ways to earn grocery savings and fuel discounts when shopping in Harris Teeter stores, on the website and app, and everywhere Mastercard is accepted

MATTHEWS, N.C., Oct. 30, 2026 /PRNewswire/ -- Harris Teeter announced the launch of the Harris Teeter Rewards World Elite Mastercard®, giving customers more ways to earn points on everyday purchases and redeem them for dollars off groceries and fuel discounts.

Building on Harris Teeter's expanded loyalty program, the new credit card helps customers earn points faster when they shop in stores, on the Harris Teeter website and app, and wherever Mastercard is accepted. Points earned with the card are automatically linked to customers' loyalty accounts and never expire while the credit card account remains active and in good standing. â¡

"At Harris Teeter, we are committed to meeting our customers' needs and rewarding their loyalty," said Danna Robinson, director of corporate affairs and customer relations for Harris Teeter. "Our new credit card builds on that commitment by giving customers more ways to earn meaningful rewards on everyday purchases, with the flexibility to save on groceries, fuel or both."

With no annual fee and no spending caps, cardholders can earn: *

- Up to 5X points on purchases made through the Harris Teeter website and app.

- 4X points at participating Harris Teeter fuel pumps.

- Up to 3X points on in-store purchases at Harris Teeter.

- 2x points on dining, utilities and travel.

- 1x points on all other eligible purchases wherever Mastercard is accepted.

Additional benefits include a $100 Welcome Bonus for eligible new cardholders who meet qualifying spending requirements^ and a $10 annual Birthday Reward.*

Cardholders also receive a complimentary HT Plus membership, offering exclusive savings and free next-day delivery on orders of $35 or more, subject to availability and applicable restrictions.+

Powered by Imprint's technology, customers can apply for and manage their credit card through the Harris Teeter app, making it easy to earn, track and redeem rewards in one place.

To learn more or apply, visit https://www.harristeeter.com/pr/rewards-mastercard or the Harris Teeter app.

About Harris Teeter:

For more than 60 years, Harris Teeter, a wholly-owned subsidiary of Kroger, has enriched lives â one meal, one family, one associate and one community at a time. Headquartered in Matthews, North Carolina, Harris Teeter employs 36,000 valued associates across more than 250 stores and 85 fuel centers in North Carolina, South Carolina, Virginia, Georgia, Maryland, Delaware, Florida, and the District of Columbia.

About Imprint

Imprint is the payments, loyalty, and intelligence platform brands like Shell, Kroger, and Booking.com use to make every transaction more valuable. Through co-branded financial products, Imprint helps brands learn from customer interactions and deliver personalized recognition and rewards. With more than two million members nationwide, the company's mission is to turn every customer into a regular. Founded in 2020, Imprint is headquartered in New York City. For more information, visit www.imprint.co.

About Mastercard

Mastercard powers economies and empowers people in 200+ countries and territories worldwide. Together with our customers, we're building a resilient economy where everyone can prosper. We support a wide range of digital payments choices, making transactions secure, simple, smart, and accessible. Our technology and innovation, partnerships and networks combine to deliver a unique set of products and services that help people, businesses and governments realize their greatest potential. mastercard.com

This card is issued by First Bank & Trust, pursuant to a license by Mastercard International Incorporated. Mastercard, the circles design, and World Elite Mastercard are registered trademarks of Mastercard International Incorporated. This credit card is operated by Imprint Payments, Inc.

â¡Points earned using the Harris Teeter Rewards Mastercard® do not expire while your account remains active and in good standing. An account is no longer active after 12 consecutive months with no settled transactions, or upon account closure. See Imprint Rewards Program Terms and Conditions for details.

*See Imprint Rewards Program Terms and Conditions and Cardholder Agreement for details.

^ Valid one time only for new cardholders. Offer cannot be combined with other promotions. Earn a $100 Harris Teeter reward after $750 in net spend on the card outside of Harris Teeter and Kroger Channels within 90 days of opening an account. Qualifying purchases exclude balance transfers, cash advances, fees and returned items. Reward is redeemable for eligible grocery purchases only; cannot be applied toward fuel purchases. Reward will expire after the end of the second month following the month in which it is issued. See Imprint Rewards Program Terms and Conditions for details.

+ See HT Plus Terms & Conditions for more details.

SOURCE Harris Teeter

Share this article

- SourceAmerica, which helps administer the AbilityOne Program, closes National Disability Employment Awareness Month (NDEAM) 2026 by highlighting progress and calling for continued action to expand disability employment opportunities.

- From 2022 to 2025, the AbilityOne workforce in the Source America network grew from 32,652 to 37,407 employees, and the average wage rose from $16.43 to $19.68 per hour.

- More than 98% of products produced within SourceAmerica's network are wholly Made in America or compliant with the Trade Agreements Act.

VIENNA, Va., Oct. 30, 2026 /PRNewswire/ -- As National Disability Employment Awareness Month (NDEAM) closes its 81st year, SourceAmerica®, is recognizing progress in disability employment and calling on employers to keep expanding opportunities for people with disabilities.

Announced by the U.S. Department of Labor's Office of Disability Employment Policy, this year's NDEAM theme, "Celebrating Value and Talent," underscores the contributions people with disabilities make to workplaces and communities nationwide.

SourceAmerica is a national nonprofit that helps administer the AbilityOne® Program to create employment opportunities for people with disabilities through federal contracts. Through the Program, employees who are blind or have significant disabilities manufacture products in America and deliver essential services that support the federal government. Today, more than 37,400 people with disabilities are employed on AbilityOne contracts throughout the SourceAmerica nonprofit network and more than 98% of products produced within the network are wholly Made in America or compliant with the Trade Agreements Act.

"Eighty-one years after NDEAM was first recognized, people with disabilities continue to demonstrate their value and talent across industries, including key manufacturing roles that help deliver mission-critical, Made in America products to federal customers and the military," said Richard Belden, SourceAmerica president and CEO.

The AbilityOne workforce in SourceAmerica's network is growing. From 2022 to 2025, it grew from 32,652 to 37,407 employees, and the average wage rose from $16.43 to $19.68 per hour.

Despite that progress, a gap remains. According to the U.S. Bureau of Labor Statistics, the unemployment rate for people with disabilities was 8.3% in 2025, more than double the 4.1% rate for people without disabilities. SourceAmerica's national network of nonprofit agencies is working to close that gap by connecting employers with talented candidates and people with disabilities with jobs in their communities.

Says Belden, "Our work does not stop when October ends. The work ahead is making sure every talented job seeker with a disability has access to meaningful employment."

As NDEAM closes, SourceAmerica encourages employers to carry this month's momentum through the rest of the year by connecting with nonprofit agencies in its network to create more employment opportunities for people with disabilities. To learn more, visit SourceAmerica.org.

About SourceAmerica

SourceAmerica is a national nonprofit that helps administer the AbilityOne Program â a program that creates employment opportunities for people with disabilities through federal product and service contracts. We are a bridge between our network contractors and federal customers, providing the resources and support they need to successfully navigate the AbilityOne Program. To learn more, visit SourceAmerica.org and follow @SourceAmerica on Facebook, X.com (formerly Twitter), Instagram, and LinkedIn.

SOURCE SourceAmerica

Share this article

- Redfin Presents Iconic Homes of America, a newly launched creative franchise, brings America's history to life through the remarkable homes and people that helped shape the nation.

- The franchise invites everyone to explore iconic homes through immersive digital experiences and free public events, starting at Philadelphia's Betsy Ross House on November 7. Register to attend on Redfin today.

SEATTLE, Oct. 30, 2026 /PRNewswire/ -- Redfin, the real estate brokerage powered by Rocket, today launched Redfin Presents Iconic Homes of America, a new creative franchise. Redfin is celebrating America's 250th anniversary by spotlighting the stories of influential homes in the American story. Featured alongside millions of homes for sale or rent on Redfin.com, these historic properties offer a unique window into the people, pivotal moments and enduring spirit that have shaped America.

Redfin will give people across the country a new way to experience American history, opening the digital doors to each featured property through a dedicated Redfin listing-style page. With immersive tours, detailed photography and compelling stories of the people who lived within the walls, Redfin Presents Iconic Homes of America will bring the past into the present. Each property will also host a free in-person event, complemented by virtual experiences that make these remarkable stories accessible to people nationwide.

The franchise kicks off with extraordinary properties:

- The Betsy Ross House in Philadelphia: A landmark associated with the creation of the American flag and the story of a pioneering craftswoman and entrepreneur whose work became part of the nation's identity.

- 1892 Bishop's Palace in Galveston, Texas: A one-of-a-kind blend of elaborate craftsmanship, Texan influence and Gilded Age ambition.

Each property will debut separately and remain on Redfin through the end of 2027.

"America's story isn't just written in history books. It's written in the homes where people have dreamed, created, persevered and changed the course of our nation," said Jonathan Mildenhall, Chief Marketing Officer of Rocket. "As we celebrate 250 years of American independence, Redfin Presents Iconic Homes of America is an invitation to rediscover the extraordinary stories behind these front doors, and to recognize that every home, in its own way, is part of the American story."

The Betsy Ross House: A Home Woven into the American Story

Built around 1740, the Betsy Ross House offers a fascinating glimpse into the determination, ingenuity and entrepreneurial spirit of a working woman during America's founding.

The Philadelphia home is associated with Betsy Ross, the upholsterer, entrepreneur and Revolutionary-era flag maker whose story became intertwined with the creation of the first American flag. While historians continue to debate parts of the familiar legend, records show Ross was an accomplished tradeswoman who made flags for the government for decades.

The home's remarkable story extends beyond the Revolutionary era. When it faced demolition in the late 19th century, Americans from across the country came together to preserve it, contributing through 10-cent memberships. It was an early demonstration of the collective pride and community spirit that continue to give historic places their meaning.

Its Redfin listing page looks beyond the legend to explore Ross as a business owner, working mother and survivor who built an extraordinary life within two small, rented rooms.

1892 Bishop's Palace: A Remarkable Gilded Age Home

Built between 1887 and 1892, Bishop's Palace was designed by Nicholas J. Clayton, Galveston's most influential architect, for lawyer and congressman Walter Gresham, his wife, Josephine, and their seven children. The home spans 52 rooms and 19,086 square feet. It became the residence of Bishop Byrne after the Catholic Church purchased it in 1923.

Every detail of the "Broadway beauty" was custom-chosen, from hand-carved woodwork throughout to a dining room ceiling mural painted by Josephine herself. At the heart of the home, an octagonal mahogany rotunda staircase rises beneath French stained glass, surrounded by finishes from Venice, Holland and North Africa.

The property also includes a few conversation pieces, among them Josephine's china collection, the original bed, Walter's desk and Bishop Byrne's player piano. It sits in Galveston's East End Historic District, a neighborhood of colorful historic homes and lush landscaping, with the Gulf only a few blocks south.

Today, Bishop's Palace stands as a one-of-a-kind blend of elaborate craftsmanship, Texan influence and Gilded Age ambition.

Redfin will highlight iconic American homes through the end of 2027. Know a home with a story worth telling? Nominate it for inclusion in the creative franchise using this form. To tour the first properties and get an alert when each new home debuts using this link.

About Redfin

Redfin is a technology-driven real estate company with the country's most-visited real estate brokerage website. As part of Rocket Companies (NYSE: RKT), Redfin is creating an integrated homeownership platform from search to close to make the dream of homeownership more affordable and accessible for everyone. Redfin's clients can see homes first with on-demand tours, easily apply for a home loan with Rocket Mortgage, and save thousands in fees while working with a top local agent.

You can find more information about Redfin and get the latest housing market data and research at https://www.redfin.com/news. For more information about Rocket Companies, visit https://www.rocketcompanies.com.

SOURCE Redfin

Share this article